BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Walsh APG, Gordon HN, Peter K, Wang X. Ultrasonic particles: An approach for targeted gene delivery. Adv Drug Deliv Rev 2021;179:113998. [PMID: 34662671 DOI: 10.1016/j.addr.2021.113998] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Schmidt TJN, Berarducci B, Konstantinidou S, Raffa V. CRISPR/Cas9 in the era of nanomedicine and synthetic biology. Drug Discov Today 2023;28:103375. [PMID: 36174966 DOI: 10.1016/j.drudis.2022.103375] [Reference Citation Analysis]
2 Zhao Z, Saiding Q, Cai Z, Cai M, Cui W. Ultrasound technology and biomaterials for precise drug therapy. Materials Today 2023. [DOI: 10.1016/j.mattod.2022.12.004] [Reference Citation Analysis]
3 Wang Z, Feng Z, Du F, Xiang X, Tang X, Qiu L, Qian Z. Recent progress in theranostic microbubbles. Chinese Chemical Letters 2023. [DOI: 10.1016/j.cclet.2023.108137] [Reference Citation Analysis]
4 Ramedani A, Sabzevari O, Simchi A. Hybrid Ultrasound-Activated Nanoparticles Based on Graphene Quantum Dots for Cancer Treatment. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.122373] [Reference Citation Analysis]
5 Rohner E, Yang R, Foo KS, Goedel A, Chien KR. Unlocking the promise of mRNA therapeutics. Nat Biotechnol 2022;40:1586-600. [PMID: 36329321 DOI: 10.1038/s41587-022-01491-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kida H, Feril LB, Irie Y, Endo H, Itaka K, Tachibana K. Influence of Nanobubble Size Distribution on Ultrasound-Mediated Plasmid DNA and Messenger RNA Gene Delivery. Front Pharmacol 2022;13:855495. [PMID: 35721213 DOI: 10.3389/fphar.2022.855495] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hsu Y, Lee W, Chu S, Chao M, Wu K, Liu R, Wong T. Influence of Acoustic Parameters and Sonication Schemes on Transcranial Blood–Brain Barrier Disruption Induced by Pulsed Weakly Focused Ultrasound. Pharmaceutics 2022;14:1207. [DOI: 10.3390/pharmaceutics14061207] [Reference Citation Analysis]
8 Tapeinos C, Gao H, Bauleth‐ramos T, Santos HA. Progress in Stimuli‐Responsive Biomaterials for Treating Cardiovascular and Cerebrovascular Diseases. Small. [DOI: 10.1002/smll.202200291] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Song L, Chen XW, Liu Y, Wang H, Li JQ. Synthetic polymer material modified by d-peptide and its targeted application in the treatment of non-small cell lung cancer. Int J Pharm 2022;619:121651. [PMID: 35288222 DOI: 10.1016/j.ijpharm.2022.121651] [Reference Citation Analysis]
10 Huang Z, Xiao Y, Guo Y, Yang H, Zhao R, Zhang J, Yu X. A cyclen-based fluoropolymer as a versatile vector for gene and protein delivery. European Polymer Journal 2022. [DOI: 10.1016/j.eurpolymj.2022.111153] [Reference Citation Analysis]
11 Liu H, Pietersz G, Peter K, Wang X. Nanobiotechnology approaches for cardiovascular diseases: site-specific targeting of drugs and nanoparticles for atherothrombosis. J Nanobiotechnology 2022;20:75. [PMID: 35135581 DOI: 10.1186/s12951-022-01279-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wang H, Qu R, Chen Q, Zhang T, Chen X, Wu B, Chen T. PEGylated Prussian blue nanoparticles for modulating polyethyleneimine cytotoxicity and attenuating tumor hypoxia for dual-enhanced photodynamic therapy. J Mater Chem B. [DOI: 10.1039/d2tb00571a] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]